TT · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $21.32B | $19.84B | $17.68B | $15.99B | $14.14B | $12.45B | $13.08B | $12.34B |
| Cost of Revenue | — | — | — | — | — | $8.65B | $9.09B | $8.58B |
| Research & Development | $347.60M | $309.60M | $252.30M | $211.20M | $193.50M | $165.00M | $174.20M | $166.70M |
| Selling, General & Administrative | $3.74B | $3.58B | $2.96B | $2.55B | $2.45B | $2.27B | $2.32B | $2.25B |
| Operating Income | $3.97B | $3.50B | $2.89B | $2.42B | $2.02B | $1.53B | $1.67B | $1.51B |
| Interest Expense | $226.70M | $238.40M | $234.50M | $223.50M | $233.70M | $248.70M | $242.80M | $221.00M |
| Other Income / (Expense) | -$62.10M | -$19.90M | -$92.20M | -$23.30M | $1.10M | $4.10M | -$28.40M | -$33.30M |
| Income Before Taxes | $3.68B | $3.24B | $2.57B | $2.17B | $1.79B | $1.29B | $1.40B | $1.26B |
| Provision for Income Taxes | $705.90M | $627.60M | $498.40M | $375.90M | $333.50M | $296.80M | $238.60M | $234.90M |
| Net Income | $2.92B | $2.57B | $2.02B | $1.76B | $1.42B | $854.90M | $1.41B | $1.34B |
| Basic EPS | $13.09 | $11.35 | $8.85 | $7.55 | $5.96 | $3.56 | $5.84 | $5.41 |
| Diluted EPS | $12.98 | $11.24 | $8.77 | $7.48 | $5.87 | $3.52 | $5.77 | $5.35 |
| Basic Shares Outstanding | 223.00M | 226.20M | 228.60M | 232.60M | 238.70M | 240.10M | 241.60M | 247.20M |
| Diluted Shares Outstanding | 224.90M | 228.40M | 230.70M | 234.90M | 242.30M | 243.10M | 244.40M | 250.10M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $15.27 | $15.24 | $15.30 | 5 | ↑4 ↓0 |
| Dec 2027 | $17.30 | $16.70 | $17.87 | 7 | ↑5 ↓0 |
| Dec 2028 | $20.19 | $19.43 | $20.96 | 2 | ↑0 ↓0 |
| Dec 2029 | $24.43 | $24.43 | $24.43 | 1 | ↑0 ↓0 |